Werewolf Therapeutics, Inc. (HOWL) vs MindWalk Holdings Corp. (HYFT)

Werewolf Therapeutics, Inc. and MindWalk Holdings Corp. are both Biotechnology companies. Werewolf Therapeutics, Inc. and MindWalk Holdings Corp. are of similar size ($49.6M and $47.1M). Werewolf Therapeutics, Inc. grew revenue faster over the last twelve months: −5.21% against −27.0%. MindWalk Holdings Corp. has the higher net margin (−105.1% vs −141.9%) and the lower return on invested capital (−464.6% vs 0.00%). Across the 17 metrics below, Werewolf Therapeutics, Inc. leads on 9 and MindWalk Holdings Corp. on 8.

Valuation

Metric HOWL HYFT Biotechnology median
P/E n/m n/m 10.60
P/S 1.99 4.19 9.40
P/B 2.98 9.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.98 4.10 9.02
Earnings yield (73.00%) (24.76%) (32.88%)
Free cash flow yield (61.47%) (18.31%) (23.13%)

Profitability

Metric HOWL HYFT Biotechnology median
Gross margin 100.00% 60.81% 68.51%
Operating margin (128.18%) (103.99%) 0.00%
Net margin (141.94%) (105.06%) 0.00%
Free cash flow margin (122.51%) (76.79%) 0.00%
Return on equity (119.86%) (122.85%) (51.96%)
Return on assets (59.31%) (58.55%) (46.06%)
Return on invested capital 0.00% (464.59%) 0.00%

Growth

Metric HOWL HYFT Biotechnology median
Revenue growth (TTM) (5.21%) (26.99%) 6.76%
EPS growth (last fiscal year) 18.40% 66.15% 29.88%
Revenue growth, 5-year CAGR — (3.83%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HOWL HYFT Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 2.91 1.84 4.97
Net debt to EBITDA 0.97 0.62 1.01

Dividend

Metric HOWL HYFT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HOWL HYFT Biotechnology median
Market cap 49.57m 47.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack